Current clinical application of serum biomarkers to detect and monitor ovarian cancer – update
In recent decades many potential serum biomarkers have been assessed in the diagnosis of ovarian cancer. Except cancer antigen 125 (CA125) and human epididymis protein 4 (HE4), none of them have been applied to everyday clinical practice. Based on extensive scientific evidence, CA125 combined with H...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Termedia Publishing House
2022-01-01
|
| Col·lecció: | Menopause Review |
| Matèries: | |
| Accés en línia: | https://www.termedia.pl/Current-clinical-application-of-serum-biomarkers-to-detect-and-monitor-ovarian-cancer-update,4,46144,1,1.html |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|